Genotyping of the rs1800440 Polymorphism in CYP1B1 Gene and the rs9258883 Polymorphism in HLA-B Gene in a Spanish Cohort of 223 Patients with Frontal Fibrosing Alopecia
Keywords:Cicatricial alopecia, Genetic loci, hair loss, HLA Antigens, pathogenesis, xenobiotics
The pathogenesis of frontal fibrosing alopecia has been linked to specific genetic variants. CYP1B1 codes for a component of the cytochrome p450 machinery that is involved in the metabolism of xenobiotic oestrogens. The study of the prevalence of polymorphisms in this gene may help to understand their role in the development of frontal fibrosing alopecia. The aim of this study is to describe the frequency of genetic variations in the alleles HLA-B*07:02 and CYP1B1 in patients with frontal fibrosing alopecia. A cross-sectional study was designed to evaluate blood samples from patients with frontal fibrosing alopecia who attended the Dermatology Department at University Hospital Ramón y Cajal (Madrid, Spain), in search of the polymorphisms rs9258883 and rs1800440 in the alleles HLA-B*07:02 and CYP1B1, respectively. A total of 223 patients were included in the study. Among the 83.8% of patients who carried the rs9258883 polymorphism in HLA-B*07:02, 58.7% were heterozygous for this variant and it was not present in 14.8% of the cases. The majority of patients with frontal fibrosing alopecia lacked the protective rs1800440 polymorphism in CYP1B1 (75.2%). This suggests a relevant role of this variant in development of frontal fibrosing alopecia. The genetic approach to this condition might influence patient prognosis and therapy options.
Kossard S, Lee MS, Wilkinson B. Postmenopausal frontal fibrosing alopecia: a frontal variant of lichen planopilaris. J Am Acad Dermatol 1997; 36: 59-66.
Kossard S. Postmenopausal frontal fibrosing alopecia. Scarring alopecia in a pattern distribution. Arch Dermatol 1994; 130: 770-774.
Iorizzo M, Tosti A. Frontal fibrosing alopecia: an update on pathogenesis, diagnosis, and treatment. Am J Clin Dermatol 2019; 20: 379-390.
Porriño-Bustamante ML, López-Nevot MÁ, Aneiros-Fernández J, Casado-Ruiz J, García-Linares S, Pedrinacci-Rodríguez S, et al. Study of human leukocyte antigen (HLA) in 13 cases of familial frontal fibrosing alopecia: CYP21A2 gene p.V281L mutation from congenital adrenal hyperplasia linked to HLA class I haplotype HLA-A*33:01; B*14:02; C*08:02 as a genetic marker. Australas J Dermatol 2019; 60: e195-e200.
McSweeney SM, Christou EAA, Dand N, Boalch A, Holmes S, Harries M. et al. Frontal fibrosing alopecia: a descriptive cross-sectional study of 711 cases in female patients from the UK. Br J Dermatol 2020; 183: 1136-1138.
Dlova N, Goh C-L, Tosti A. Familial frontal fibrosing alopecia. Br J Dermatol 2013; 168: 220-222.
Photiou L, Nixon RL, Tam M, Green J, Yip L. An update of the pathogenesis of frontal fibrosing alopecia: what does the current evidence tell us? Australas J Dermatol 2019; 60: 99-104.
Petukhova L, Duvic M, Hordinsky M, Norris D, Price V, Shimomura Y, et al. Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature 2010; 466: 113-117.
Kanti V, Constantinou A, Reygagne P, Vogt A, Kottner J, Blume-Peytavi U. Frontal fibrosing alopecia: demographic and clinical characteristics of 490 cases. J Eur Acad Dermatology Venereol 2019; 33: 1976-1983.
Tziotzios C. Molecular exploration of frontal fibrosing alopecia - doctoral thesis. 2019. [accessed 2022 Jun 14]. Available from https://kclpure.kcl.ac.uk/portal/en/theses/molecular-exploration-of-frontal-fibrosing-alopecia(5a7dbdd0-ac16-44a7-916d-fee3fd0eebfa).html.
Tziotzios C, Stefanato CM, Fenton DA, Simpson MA, McGrath JA. Frontal fibrosing alopecia: reflections and hypotheses on etiology and pathogenesis. Exp Dermatol 2016; 25: 847-852.
Tziotzios C, Petridis C, Dand N, Ainali C, Saklatvala JR, Pullabhatla V, et al. Genome-wide association study in frontal fibrosing alopecia identifies four susceptibility loci including HLA-B*07:02. Nat Commun 2019; 10: 1-9.
Saceda-Corralo D, Moreno-Arrones ÓM, Fonda-Pascual P, et al. Development and validation of the Frontal Fibrosing Alopecia Severity Score. J Am Acad Dermatol 2018; 78: 522-529.
Ramos PM, Garbers LEFM, Silva NSB, Castro CFB, Andrade HS, Souza AS, et al. A large familial cluster and sporadic cases of frontal fibrosing alopecia in Brazil reinforce known human leucocyte antigen (HLA) associations and indicate new HLA susceptibility haplotypes. J Eur Acad Dermatol Venereol 2020; 34: 2409-2413.
Navarro-Belmonte MR, Navarro-López V, Ramírez-Boscà A, et al. Case series of familial frontal fibrosing alopecia and a review of the literature. J Cosmet Dermatol 2015; 14: 64-69.
Tziotzios C, Fenton DA, Stefanato CM, McGrath JA. Familial frontal fibrosing alopecia. J Am Acad Dermatology 2015; 73: e37.
Harries MJ, Meyer K, Chaudhry I, et al. Lichen planopilaris is characterized by immune privilege collapse of the hair follicle's epithelial stem cell niche. J Pathol 2013; 231: 236-247.
Chan D, Kartono F, Ziegler R, Abdulwahab N, DiPaola N, Flynn J WH, et al. Absence of HLA-DR1 positivity in 2 familial cases of frontal fibrosing alopecia. J Am Acad Dermatol 2014; 71: e208-e210.
Faiq M, Dada R, Sharma R, Saluja D, Dada T. CYP1B1: a unique gene with unique characteristics. Curr Drug Metab 2014; 15: 893-914.
Carrera AN, Grant MKO, Zordoky BN. CYP1B1 as a therapeutic target in cardio-oncology. Clin Sci 2020; 134: 2897-2927.
Tang YM, Wo YYP, Stewart J, Hawkins AL, Griffin CA, Sutter TR, et al. Isolation and characterization of the human cytochrome p450 CYP1B1 gene. J Biol Chem 1996; 271: 28324-28330.
Shimada T, Gillam EMJ, Sutter TR, Strickland PT, Guengerich FP, Yamazaki H. Oxidation of xenobiotics by recombinant human cytochrome P450 1B1. Drug Metab Dispos 1997; 25: 617-622.
Sowers MFR, Wilson AL, Kardia SR, Chu J, McConnell DS. CYP1A1 and CYP1B1 polymorphisms and their association with estradiol and estrogen metabolites in women who are premenopausal and perimenopausal. Am J Med 2006; 119: S44-51.
Zhou L. AHR function in lymphocytes: emerging concepts. Trends Immunol 2016; 37: 17-31.
Fernández-Gallego N, Sánchez-Madrid F, Cibrian D. Role of AHR ligands in skin homeostasis and cutaneous inflammation. Cells 2021; 10: 1-27.
Karnik P, Tekeste Z, McCormick TS, Gilliam AC, Price VH, Cooper KD, et al. Hair follicle stem cell-specific pparγ deletion causes scarring alopecia. J Invest Dermatol 2009; 129: 1243-1257.
Doche I, Pagliari C, Hordinsky MK, Wilcox GL, Rivitti-Machado MCM, Romiti R, et al. Overexpression of the aryl hydrocarbon receptor in frontal fibrosing alopecia and lichen planopilaris: a potential pathogenic role for dioxins?: an investigational study of 38 patients. J Eur Acad Dermatology Venereol 2020; 34: e326-e329.
Bandiera S, Weidlich S, Harth V, Broede P, Ko Y, Friedberg T. Proteasomal degradation of human CYP1B1: effect of the Asn453Ser polymorphism on the post-translational regulation of CYP1B1 expression. Mol Pharmacol 2005; 67: 435-443.
How to Cite
Copyright (c) 2023 David Saceda-Corralo, Daniel Ortega-Quijano, Gloria Muñoz-Martín, Óscar M. Moreno-Arrones, Cristina Pindado-Ortega, Tuntas Rayinda, Ana Melián-Olivera, Carlos Azcárraga-Llobet, Patricia Burgos-Blasco, María Elena Castañeda-Bermúdez, Francisco J. del Castillo, Sergio Vañó-Galván
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.